Learn About Hepatoblastoma
- Hepatoblastoma
UPMC Children's Hospital Of Pittsburgh, Pediatric Transplant Services
Rakesh Sindhi, MD, FACS, is a pediatric abdominal transplant surgeon, board-certified in surgery by the American Board of Surgery. He is co-director of Pediatric Transplantation, director of Pediatric Transplant Research, and professor of surgery at the University of Pittsburgh School of Medicine. Dr. Sindhi is rated as an Elite provider by MediFind in the treatment of Hepatoblastoma. His top areas of expertise are Hepatoblastoma, Biliary Atresia, Liver Failure, Liver Transplant, and Small Bowel Resection.
Eiso Hiyama practices in Hiroshima, Japan. Hiyama is rated as an Elite expert by MediFind in the treatment of Hepatoblastoma. Their top areas of expertise are Hepatoblastoma, Neuroblastoma, Liver Cancer, Pancreaticoduodenectomy, and Hepatectomy.
Stefano Cairo practices in Evry, France. Mr. Cairo is rated as an Elite expert by MediFind in the treatment of Hepatoblastoma. His top areas of expertise are Hepatoblastoma, Liver Cancer, Breast Cancer, and Triple-Negative Breast Cancer.
Summary: Researchers are looking for new ways to treat children with hepatoblastoma or rhabdomyosarcoma (RMS) that has relapsed or is refractory: * Hepatoblastoma is a common liver cancer in babies and very young children * RMS is a cancer that starts in muscle cells, often in a child's head and neck, bladder, arms, or legs * Relapsed means the cancer came back after treatment * Refractory means the cancer...
Summary: 3CAR is being done to investigate an immunotherapy for patients with solid tumors. It is a Phase I clinical trial evaluating the use of autologous T cells genetically engineered to express B7-H3-CARs for patients ≤ 21 years old, with relapsed/refractory B7-H3+ solid tumors. This study will evaluate the safety and maximum tolerated dose of B7-H3-CAR T cells.The purpose of this study is to find the ...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center